Rockefeller Capital Management L.P. Arrowhead Pharmaceuticals, Inc. Transaction History

Rockefeller Capital Management L.P.

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Mar 06, 2023	BUY	$28.0 - $40.56 $420 - $608	15 Added 6.91%	232 $9,000
Q3 2022 Nov 02, 2022	SELL	$29.63 - $48.31 $33,274 - $54,252	-1,123 Reduced 83.81%	217 $7,000
Q2 2022 Aug 12, 2022	SELL	$27.79 - $50.61 $101,544 - $184,928	-3,654 Reduced 73.17%	1,340 $47,000
Q1 2022 May 13, 2022	BUY	$39.62 - $69.97 $911 - $1,609	23 Added 0.46%	4,994 $229,000
Q4 2021 Feb 14, 2022	BUY	$58.09 - $82.51 $163,813 - $232,678	2,820 Added 131.1%	4,971 $329,000
Q3 2021 Nov 12, 2021	BUY	$58.38 - $84.96 $42,734 - $62,190	732 Added 51.59%	2,151 $134,000
Q2 2021 Aug 10, 2021	SELL	$62.15 - $90.32 $389,742 - $566,396	-6,271 Reduced 81.55%	1,419 $117,000
Q1 2021 May 11, 2021	BUY	$61.35 - $90.47 $185,154 - $273,038	3,018 Added 64.6%	7,690 $509,000
Q4 2020 Feb 12, 2021	BUY	$43.82 - $85.37 $2,015 - $3,927	46 Added 0.99%	4,672 $358,000
Q3 2020 Nov 13, 2020	BUY	$33.21 - $51.27 $33,210 - $51,270	1,000 Added 27.58%	4,626 $199,000
Q2 2020 Aug 12, 2020	BUY	$26.12 - $43.27 $11,127 - $18,433	426 Added 13.31%	3,626 $157,000
Q1 2020 May 12, 2020	BUY	$20.56 - $63.12 $65,792 - $201,984	3,200 New	3,200 $92,000

295

91.1M

155K

426K

Ticker ARWR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 105,849,000
Market Cap $2.23B
Description
Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...

Get notified when there are updates to the investment portfolio of Rockefeller Capital Management L.P., based on Form 13F filings with the SEC.

Stay updated on Rockefeller Capital Management L.P. with notifications on news.